ACAD
49.3
+1.74
+3.66%
AEMD
9.58
-0.42
-4.20%
APRI
1.47
-0.05
-3.29%
ARNA
4.08
+0.09
+2.26%
ATEC
1.36
-0.01
-0.73%
CNAT
5.02
+0.12
+2.45%
CRXM
0.3
+0.01
+1.73%
CYTX
0.44
+0.04
+9.97%
DXCM
83.41
+1.71
+2.09%
GNMK
8.83
-0.27
-2.97%
HALO
23.71
+0.91
+3.99%
ILMN
217.82
+0.55
+0.25%
INNV
0.155
-0.003
-1.899%
INO
7.4
+0.22
+3.06%
ISCO
0.043
-0.005
-10.5263%
ISIS
54.4
+0.72
+1.34%
LGND
105.84
+3.29
+3.21%
LPTN
0.28
0.00
0.00%
MBVX
1.59
-0.01
-0.62%
MEIP
1.57
+0.02
+1.29%
MNOV
3.65
-0.16
-4.20%
MRTX
29.3
+1.06
+3.75%
MSTX
0.46
-0.01
-1.63%
NBIX
51.92
+2.58
+5.23%
NUVA
50.47
+0.88
+1.77%
ONCS
6.27
+0.24
+3.98%
ONVO
3.37
-0.01
-0.30%
OREX
4.39
+0.18
+4.28%
OTIC
27.28
+0.3
+1.11%
QDEL
21.88
-0.51
-2.28%
RCPT
227.16
+0.07
+0.03%
RGLS
8.92
+0.24
+2.76%
RMD
56.7
+1.53
+2.77%
SCIE
0.02
0.00
+5.26%
SPHS
0.91
+0.05
+5.8488%
SRNE
20.41
-3.29
-13.88%
TROV
8.35
-0.17
-2.00%
VICL
0.64
+0.03
+4.92%
ZGNX
20.14
+0.27
+1.36%
ACAD
49.3
+1.74
+3.66%
AEMD
9.58
-0.42
-4.20%
APRI
1.47
-0.05
-3.29%
ARNA
4.08
+0.09
+2.26%
ATEC
1.36
-0.01
-0.73%
CNAT
5.02
+0.12
+2.45%
CRXM
0.3
+0.01
+1.73%
CYTX
0.44
+0.04
+9.97%
DXCM
83.41
+1.71
+2.09%
GNMK
8.83
-0.27
-2.97%
HALO
23.71
+0.91
+3.99%
ILMN
217.82
+0.55
+0.25%
INNV
0.155
-0.003
-1.899%
INO
7.4
+0.22
+3.06%
ISCO
0.043
-0.005
-10.5263%
ISIS
54.4
+0.72
+1.34%
LGND
105.84
+3.29
+3.21%
LPTN
0.28
0.00
0.00%
MBVX
1.59
-0.01
-0.62%
MEIP
1.57
+0.02
+1.29%
MNOV
3.65
-0.16
-4.20%
MRTX
29.3
+1.06
+3.75%
MSTX
0.46
-0.01
-1.63%
NBIX
51.92
+2.58
+5.23%
NUVA
50.47
+0.88
+1.77%
ONCS
6.27
+0.24
+3.98%
ONVO
3.37
-0.01
-0.30%
OREX
4.39
+0.18
+4.28%
OTIC
27.28
+0.3
+1.11%
QDEL
21.88
-0.51
-2.28%
RCPT
227.16
+0.07
+0.03%
RGLS
8.92
+0.24
+2.76%
RMD
56.7
+1.53
+2.77%
SCIE
0.02
0.00
+5.26%
SPHS
0.91
+0.05
+5.8488%
SRNE
20.41
-3.29
-13.88%
TROV
8.35
-0.17
-2.00%
VICL
0.64
+0.03
+4.92%
ZGNX
20.14
+0.27
+1.36%
Home » Bio: Brian Orelli

Bio: Brian Orelli

Somewhere between his graduate thesis at the University of Chicago on BRCA1 and his postdoctoral fellowship in DNA repair at the Ludwig Institute, Brian realized he enjoyed analyzing other people’s data more than running his own experiments. And thus a career in science writing was born. Brian provides freelance articles for The Motley Fool, BioWorld, Nature Biotechnology, and anyone else that will let him write at the intersection of drugs and business.